Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07278)

• Formulation Name: Enalapril 2.5 mg tablet
• Company: BTA Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Enalapril	(DMNFUZR)	Congestive heart failure	BD10	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Sodium bicarbonate	(E00424)	516892	Alkalizing agent; Diluent
Sodium stearate	(E00453)	2724691	Emulsifying agent; Gelling agent; Glidant; Modified-release agent; Stiffening agent; lubricant